MedPath

Evolva SA

🇨🇭Switzerland
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.evolvabio.com

Clinical Trials

2

Active:1
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EV-077 in Type 2 Diabetic Subjects

Phase 2
Terminated
Conditions
Type 2 Diabetes
Interventions
Drug: Placebo
First Posted Date
2012-03-12
Last Posted Date
2013-06-17
Lead Sponsor
Evolva SA
Target Recruit Count
33
Registration Number
NCT01551381
Locations
🇩🇪

Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany

News

No news found
© Copyright 2025. All Rights Reserved by MedPath